Evidence map›Paper›PMID 28122636›Full record

ArticleRetrovirology2017

Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures.

Kyle J Nakamura, Laura Heath, Edwin R Sobrera, Thomas A Wilkinson, Katherine Semrau, Chipepo Kankasa, Nicole H Tobin, Nicholas E Webb, Benhur Lee, Donald M Thea and 3 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Kyle J NakamuraDivision of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Laura HeathDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Edwin R SobreraDivision of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Thomas A WilkinsonDivision of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Katherine SemrauDivision of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, and Ariadne Labs, Boston, MA, USA.
Chipepo KankasaUniversity Teaching Hospital, University of Zambia, Lusaka, Zambia.
Nicole H TobinDivision of Pediatric Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA, USA.
Nicholas E WebbDivision of Pediatric Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA, USA.
Benhur LeeDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Donald M TheaDivision of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, and Ariadne Labs, Boston, MA, USA.
Louise KuhnDepartment of Epidemiology, Columbia University, New York, NY, USA.
James I MullinsDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Grace M AldrovandiDivision of Pediatric Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA, USA. GAldrovandi@mednet.ucla.edu.
Children's Hospital of Los Angeles · USUniversity of California, Los Angeles · USHarvard University · USUniversity of Washington · USColumbia University · USIcahn School of Medicine at Mount Sinai · USUniversity Teaching Hospital · ZM

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Sharon A Nachman · 2011 to 2026
$278.1M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Short Exclusive Breastfeeding to Reduce Postnatal Transmission of HIVR01HD039611 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI THEA, DONALD M · 2000 to 2006
$8.0M
Occurrence and Outcome of Dual HIV-1 InfectionR37AI047734 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2005 to 2014
$5.9M
Pathogenesis of Mother to Child Transmission of HIVR01HD040777 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALDROVANDI, GRACE M · 2002 to 2011
$4.4M
NIAID NIH HHS P30 AI027757NIAID NIH HHS R37 AI047734NIAID NIH HHS UM1 AI068632NICHD NIH HHS R01 HD039611NICHD NIH HHS R01 HD040777
6 · The paper itself

Abstract

backgroundMother-to-child transmission of human immunodeficiency virus-type 1 (HIV-1) poses a serious health threat in developing countries, and adequate interventions are as yet unrealized. HIV-1 infection is frequently initiated by a single founder viral variant, but the factors that influence particular variant selection are poorly understood.

resultsOur analysis of 647 full-length HIV-1 subtype C and G viral envelope sequences from 22 mother-infant pairs reveals unique genotypic and phenotypic signatures that depend upon transmission route. Relative to maternal strains, intrauterine HIV transmission selects infant variants that have shorter, less-glycosylated V1 loops that are more resistant to soluble CD4 (sCD4) neutralization. Transmission through breastfeeding selects for variants with fewer potential glycosylation sites in gp41, are more sensitive to the broadly neutralizing antibodies PG9 and PG16, and that bind sCD4 with reduced cooperativity. Furthermore, experiments with Affinofile cells indicate that infant viruses, regardless of transmission route, require increased levels of surface CD4 receptor for productive infection.

conclusionsThese data provide the first evidence for transmission route-specific selection of HIV-1 variants, potentially informing therapeutic strategies and vaccine designs that can be tailored to specific modes of vertical HIV transmission.

Indexed as

GenotypeInfectious Disease Transmission, VerticalSelection, GeneticBreast FeedingCohort Studiesenv Gene Products, Human Immunodeficiency VirusFemaleHIV-1HIV InfectionsHumansInfantInfant, NewbornMaleMaternal-Fetal ExchangePregnancySequence Analysis, DNAenv Gene Products, Human Immunodeficiency VirusBroadly neutralizing antibodiesCD4EnvelopeGlycosylationHIV-1Mother-to-child transmission

Identifiers

PMID28122636
PMCPMC5267468
OpenAlexW2581762880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.